Small Business Innovation Research (SBIR) Program for Rare Diseases and Young Pediatric Populations
National Institutes of Health
Description
The SBIR Program offers grants to help small businesses advance technologies they have developed. This opportunity is for small businesses with projects previously funded by SBIR or STTR Phase II awards, focusing on rare diseases or young pediatric populations. The aim is to support further research and development to achieve regulatory approval and commercialization, encouraging partnerships with third-party investors.
The SBIR Program aims to facilitate the commercialization of technologies developed by small business concerns (SBCs). This Notice of Funding Opportunity (NOFO) invites small businesses to submit SBIR grant applications to support later stage research and development for promising projects that …
Source
Grant ID
RFA-HL-26-015
Agency
National Institutes of Health
Subcategory/Subagency
National Heart, Lung, and Blood Institute
Key Dates
Opportunity Released
November 18, 2024
Open for Submission
November 18, 2024
Submission Deadline
February 26, 2027
Application Window Closes
February 26, 2027
Eligibility
The following categories of applicants are invited to apply:
- For-Profit Organizations: U.S. Small Business Concerns (SBCs) only (organized for profit; U.S. place of business; operates primarily in the U.S. or makes a significant contribution to the U.S. economy; ≤500 employees including affiliates).
- For-Profit Organizations: U.S. Small Businesses majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms (SBIR-only provision; no single investor may own >50% unless that investor itself qualifies as an SBC owned/controlled by U.S. individuals).
- For-Profit Organizations: Joint ventures that qualify as SBCs under SBIR rules (each venturing entity must meet SBIR ownership requirements; JV must comply with 13 CFR 121.705(b)).
Similar opportunities
- Notice of Funding Opportunity Purpose
National Institutes of Health
- Small Business Innovation Research (SBIR) Program: Phase IIB Competing Renewal Awards
National Institutes of Health
- Notice of Funding Opportunity Purpose
National Institutes of Health
- PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Department of Health and Human Services
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
Department of Health and Human Services